Myocardial Tissue Characterization in Danon Disease
Fei Chen,Mao Chen
DOI: https://doi.org/10.1148/radiol.222333
IF: 19.7
2023-01-01
Radiology
Abstract:HomeRadiologyVol. 307, No. 2 PreviousNext Reviews and CommentaryFree AccessImages in RadiologyMyocardial Tissue Characterization in Danon DiseaseFei Chen, Mao Chen Fei Chen, Mao Chen Author AffiliationsFrom the Department of Cardiology, Laboratory of Heart Valve Disease, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, PR China.Address correspondence to M.C. (email: [email protected]).Fei ChenMao Chen Published Online:Jan 17 2023https://doi.org/10.1148/radiol.222333MoreSectionsPDF ToolsImage ViewerAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinked In A 14-year-old boy was referred for cardiac MRI, which showed mild left ventricular (LV) wall thickening to 13 mm (Figure, A). No edema signal or late gadolinium enhancement (LGE) was observed (Figure, A, B). Native myocardial T1 was elevated (1331 msec; reference, 1114–1290 msec), but extracellular volume (ECV) fraction (25%) and myocardial T2 (38 msec) were normal (Figure, C–E). LV hypertrophy associated with storage disorders was suspected.Baseline and follow-up cardiac MRI scans in a young boy with Danon disease. (A–E) Cardiac MRI scans at age 14 years show (A) mild left ventricular (LV) hypertrophy (maximum thickness, 13 mm; LV mass index, 93 g/m2) with no edema, (B) late gadolinium enhancement (LGE), (C) abnormal global native T1 value of 1331 msec (reference, 1114–1290 msec), (D) normal global extracellular volume (ECV) fraction of 25% (reference, 21%–33%), and (E) normal global T2 value of 38 msec (reference, 33–44 msec). (F–J) Cardiac MRI scans at age 19 years show (F) extreme LV hypertrophy (maximum thickness, 43 mm; LV mass index, 476 g/m2) with extensive midwall-dominant edema, (G) LGE, and (H-J) increased global tissue characterization metrics ([H] native T1 value [1478 msec], [I] extracellular volume fraction [44%], and [J] T2 value [51 msec]). CE-bSSFP = contrast-enhanced balanced steady-state free precession.Download as PowerPointOpen in Image Viewer At age 19 years, a repeated cardiac MRI showed a marked increase in LV wall thickness to 43 mm (Figure, F). LGE manifested in a nonischemic pattern of midwall-dominant involvement, sparing the basal septum, and with a base-to-apex increasing tendency (Figure, G). Myocardial T1 had increased (1478 msec) since the last examination, as had ECV fraction (44%) (Figure, H, I). T2 imaging showed myocardium edema signals and increased myocardial T2 (51 msec) (Figure, F, J).Genetic testing was indicated and identified a pathogenic mutation in the lysosome-associated membrane protein 2 (LAMP2) gene (c.190_191delGT), suggesting the diagnosis of Danon disease (1). Danon disease, or LAMP2 deficiency (glycogen type 2b storage disease), predominantly affects cardiac and skeletal muscles and also includes neurologic manifestations. It may be underrecognized as a cause of hypertrophic cardiomyopathy in childhood and early adulthood (2,3). Cardiac MRI could reveal cardiomyocyte injury, edema, and fibrosis in the progression of Danon disease, as well as isolated intracellular autophagic vacuoles accumulation during the early stage.Disclosures of conflicts of interest: F.C. No relevant relationships. M.C. No relevant relationships.References1. D’souza RS, Levandowski C, Slavov D, et al. Danon disease: clinical features, evaluation, and management. Circ Heart Fail 2014;7(5):843–849. Crossref, Medline, Google Scholar2. Wei X, Zhao L, Xie J, et al. Cardiac Phenotype Characterization at MRI in Patients with Danon Disease: A Retrospective Multicenter Case Series. Radiology 2021;299(2):303–310. Link, Google Scholar3. Hanneman K. Cardiac MRI in Danon Disease: Sex-specific Differences and Characteristic Imaging Findings. Radiology 2021;299(2):311–312. Link, Google ScholarArticle HistoryReceived: Sept 18 2022Revision requested: Sept 20 2022Revision received: Sept 21 2022Accepted: Sept 22 2022Published online: Jan 17 2023 FiguresReferencesRelatedDetailsRecommended Articles Hypertrophic Cardiomyopathy from A to Z: Genetics, Pathophysiology, Imaging, and ManagementRadioGraphics2016Volume: 36Issue: 2pp. 335-354Cardiac MRI of Hereditary CardiomyopathyRadioGraphics2022Volume: 42Issue: 3pp. 625-643MRI Characteristics, Prevalence, and Outcomes of Hypertrophic Cardiomyopathy with Restrictive PhenotypeRadiology: Cardiothoracic Imaging2020Volume: 2Issue: 4MRI T1 Mapping in Hypertrophic Cardiomyopathy: Evaluation in Patients Without Late Gadolinium Enhancement and Hemodynamic ObstructionRadiology2019Volume: 294Issue: 2pp. 275-286Myocardial Activity at 18F-FAPI PET/CT and Risk for Sudden Cardiac Death in Hypertrophic CardiomyopathyRadiology2022Volume: 306Issue: 2See More RSNA Education Exhibits Differential Diagnosis of Cardiac Amyloidosis: Pearls and PitfallsDigital Posters2022MRI Mapping in the study of Myocardial DiseaseDigital Posters2022All That Enhances Late, Is Not Ischemic : Pattern Based Approach Towards Late Gadolinium Enhancement In Cardiomyopathies, A Primer For Residents Digital Posters2021 RSNA Case Collection Cardiac fibromaRSNA Case Collection2020Hypertrophic cardiomyopathyRSNA Case Collection2020Primary LymphedemaRSNA Case Collection2022 Vol. 307, No. 2 Metrics Altmetric Score PDF download